| Dose | Route | Schedules | Cold Chain | Storage |
|---|---|---|---|---|
| 2 g/kg | Single Cycle over 2 or 3 days | Varies | >1yr at +4 0C and 3 months |
|
Potential
Available, scalable, expensive |
Therapeutic Goal shortening time to sputum clearance | |
|
Potential Biomarkers
|
Initial Target Population Drug-sensitive |
|
Toxicity
Known safety profile |
Next Step
Phase IIa in TB patients |
| Dose | Route | Schedules | Cold Chain | Storage |
|---|---|---|---|---|
| 2 g/kg | Single Cycle over 2 or 3 days | Varies | >1yr at +4 0C and 3 months |